![]() |
市場調查報告書
商品編碼
1497764
採血管市場:按產品類型、材料類型和最終用戶分類 - 全球預測 2024-2030Blood Collection Tubes Market by Product Type (EDTA Tubes, Heparin Tubes, Plasma Separation Tube), Material Type (Glass, Plastic), End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年採血管市場規模為27.1億美元,預計2024年將達29.4億美元,2030年將達46.8億美元,複合年成長率為8.10%。
Investigation_KEYWORD 是一種用於收集、儲存和運輸血液樣本的設備,用於各種臨床應用,包括診斷、輸血、研究、藥物發現、基因分析和法醫學。由於人口老化需要定期對慢性疾病進行血液檢查,以及對早期診斷和預防性醫療措施的需求不斷增加,採血管的採用不斷增加。真空管技術的進一步進步可確保在最小污染的情況下準確提取樣品、實驗室工作流程自動化以及公眾定期健康檢查的意識正在支持市場需求。然而,有關產品品質標準的嚴格監管準則以及樣品處理過程中交叉污染的風險正在阻礙市場成長。除此之外,改進儲存解決方案的材料進步、提高照護現場診斷準確性的生物標記物整合以及支援物聯網的智慧管的開拓預計將為市場創造機會主義局面。
主要市場統計 | |
---|---|
基準年[2023] | 27.1億美元 |
預測年份 [2024] | 29.4億美元 |
預測年份 [2030] | 46.8億美元 |
複合年成長率(%) | 8.10% |
區域洞察
在美洲,人口老化的加劇導致慢性病盛行率的增加,導致採血管的使用增加。此外,該地區在醫療保健旅遊和早期疾病診斷方面的支出能力強勁。在EMEA地區,醫療基礎設施發達,主要製造商的存在增加了產品改進的研發成本,這正在支持市場開拓。此外,在歐洲、中東和非洲地區,由於醫療保健投資的增加,中東和非洲為採血管產品提供了潛在的成長機會。各國政府正在鼓勵官民合作關係來改善衛生基礎設施,這可以增加對採血管等高品質診斷產品的需求。亞太地區由於人口眾多,需要採血管作為診斷用管,因此市場前景良好。該地區新興經濟體醫療保健產業的開拓,以及政府致力於提供無障礙醫療保健服務的舉措,預計將支持市場成長。
FPNV定位矩陣
FPNV定位矩陣對於評估供應商在採血管市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對採血管市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析也為該領域的競爭性質提供了寶貴的見解,包括累積研究期、片段化優勢和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在採血管市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[182 Pages Report] The Blood Collection Tubes Market size was estimated at USD 2.71 billion in 2023 and expected to reach USD 2.94 billion in 2024, at a CAGR 8.10% to reach USD 4.68 billion by 2030.
Blood collection tubes are the devices used for collecting, storing, and transporting blood samples in various clinical applications, including diagnostics, transfusions, research studies, drug discovery, genetic profiling, and forensic science. The aging population requiring regular blood tests for chronic diseases and increased demand for early diagnosis and preventive healthcare measures have increased the adoption of blood collection tubes. Further advancements in vacuum tube technology ensuring accurate sample extraction with minimal contamination, automation in laboratory workflows, and public awareness leading to regular medical check-ups have supported the market demand. However, stringent regulatory guidelines on product quality standards and cross-contamination risks during sample handling procedures hinder market growth. Apart from this, material advancements for improved storage solutions, biomarker integration to enhance diagnostic accuracy at point-of-care, and the development of IoT-enabled smart tubes are expected to create an opportunistic landscape for the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.71 billion |
Estimated Year [2024] | USD 2.94 billion |
Forecast Year [2030] | USD 4.68 billion |
CAGR (%) | 8.10% |
Regional Insights
In the Americas region, the increasing geriatric population leading to the prevalence of chronic diseases has increased the use of blood collection tubes. Moreover, healthcare tourism and spending capabilities for early disease diagnostics have flourished in this region. In the EMEA region, well-developed healthcare infrastructure and the presence of the major manufacturers leading to increased spending on research & development for product improvements have supported the market demand. Further, In the EMEA region, the Middle East and Africa demonstrate potential growth opportunities for blood collection tube products due to increasing healthcare investments in these regions. Governments are encouraging public-private partnerships to improve medical infrastructure, which may increase the demand for quality diagnostic products such as blood collection tubes. Asia Pacific region showcased an opportunistic landscape for the market in the face of large population countries requiring blood collection tubes for diagnostic tubes. The developing healthcare sector across the many economies in the region, along with government initiatives focusing on providing accessible healthcare services, is expected to support the market growth.
Market Insights
The market dynamics represent an ever-changing landscape of the Blood Collection Tubes Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Blood Collection Tubes Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Blood Collection Tubes Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Husky Installs First-of-Its-Kind Medical Molding System in India
Husky implemented a state-of-the-art medical molding system in India, marking a significant milestone in the industry. This innovative system is designed exclusively for the production of blood collection tubes, catering to the specific needs of the medical sector. With the integration of an all-electric injection molding machine and two adjacent Husky HyPET HPP5 systems, the system streamlines and optimizes the entire production cycle. [Published On: 2023-06-02]
CML Biotech installs integrated blood collection tube manufacturing machine
CML Biotech introduced integrated blood collection tube manufacturing machine. This cutting-edge machine is capable of completing multiple processes in one go, including the production of plastic molds and the filling of tubes with additives. By automating these tasks, CML Biotech expects to achieve significant cost savings of 25-30% in labor expenses, while also improving overall efficiency by 30-35%. Moreover, this innovative machine has been meticulously designed to adhere to high product quality and safety standards, ensuring the utmost reliability for medical professionals and patients alike. [Published On: 2023-05-27]
MHT Mold & Hotrunner Technology and KEBO Partner on Blood Collection Tubes (BCT)
MHT Mold & Hotrunner Technology (MHT) and KEBO have formed a strategic partnership to introduce a new product line, Blood Collection Tubes (BCT). MHT's automated mold system is seamlessly integrated with KEBO's medical-grade operatory management system, ensuring utmost accuracy and quality. This collaboration provides healthcare facilities with a cost-effective and reliable solution for the safe collection, storage, and transportation of blood samples. [Published On: 2023-01-26]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Blood Collection Tubes Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Blood Collection Tubes Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Becton, Dickinson & Company, Bioscientia Healthcare, Biosigma S.p.A., Cardinal Health, Inc., CML BIOTECH LIMITED, Convergent Technologies GmbH, FL Medical S.R.L., Greiner Bio One International Gmbh, Guangzhou Improve Medical Instruments Co. Ltd., Haemonetics Corporation, Labtech S.r.l., Medtronic plc, Micsafe Medical Group, Nanjing Vazyme Medical Technology Co., Ltd., Nipro Medical Corporation, QIAGEN N.V., Radiometer India, SARSTEDT AG & Co. KG, Smiths Medical, Inc. by ICU Medical, Inc., Sunphoria Co., Ltd., Terumo Corporation, and Vyaire Medical, Inc..
Market Segmentation & Coverage